RSNA 2007
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
Breast cancer
The 5th World Conference on Breast Cancer
"Come and experience the great Canadian Prairie Hospitality!" say the organisers of the 5th World Conference on Breast Cancer (WCBC), to be held in June next year in Winnipeg, Manitoba - the "cultural cradle of the nation, gateway to the Canadian west, and a meeting place for over 6,000 years," the WCBC Foundation points out.
Mammography Screening in Germany
Despite efforts in recent years to reduce the number of deaths caused by breast cancer it is still the most common cancer occurring in women. Approx. 47,500 new cases of the disease appear in Germany per year, a situation comparable with other European countries and with the USA. In 2004 alone, 17,592 women died from the sequela of a breast carcinoma (Federal Statistics Office statistics on…
State governments unite to lower mortality
Australia - The Australian Institute of Health and Welfare has reported a 26% decrease in the breast cancer mortality rate among women aged 50-69 years between 1990 and 2004.
Are New Techniques Needed in Modern Sonography?
Breast cancer is the most frequently occurring malignant tumour worldwide. Of the more than one million newly diagnosed cases each year, the incidence among women in Germany alone is more than 50,000. That means that every tenth woman is stricken by breast cancer at some point in her life. It numbers among the most frequent causes of death by cancer 1,2,3 , with the average age of onset being…
In-vivo and in-vitro diagnostics in molecular medicine
In molecular medicine - and particularly in oncology - Siemens Medical Solutions is concentrating on further development of the FDG (fluorodeoxyglucose) biomarker to improve identification of certain tumours.
Steep drop in breast cancer rates
USA - A steep drop in breast cancer rates between 2002 and 2003 correlates with the decline in hormone therapy use, according to research froma the American Cancer Society (ACS).
World's largest gathering of cancer specialists told: Mammography is still key to survival
Rapid diagnosis and treatment are the keys to breast cancer survival - and an elastogram mammography continues to play a central role in breast cancer detection according to research presented recently in Chicago, at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), writes Ian Mason.
The 27th Annual Convention of the German Society for Senology
Congress President Professor Juergen Dunst MD praises major advances and multidisciplinary efforts, and outlines future hopes for breast cancer patients
Screening: Patients respond well to web-based reminders
USA - Web-based mail and phone reminder software significantly increased the percentage of patients who received preventive health services, according to a study led by Rajeev Chaudhry MBBS, at the Mayo Clinic, published in May in The Archives of Internal Medicine.
27 th Annual Meeting of the German Society of Senology
This year´s congress of the German Society of Senology (June 21.-23. in Lübeck, Germany) will deal with latest developments in the diagnosis and therapy of breast cancer like screening and early detection methods or new diagnostic modalities.
Electron intra-operative therapy
`ELIOT means that single-fraction radiation of 21 Gy is delivered directly to the tumour bed during a surgical intervention, to a depth of about 3 cm,´ Professor Prott explained.
Low compliance with guidance harms patients
By Henning von Eicke of Roche Diagnostics GmbH
Breast cancer screening
20% of all cancers diagnosed annually among Lithuanian women is cancer of the breast. Screening programms should reduce this number.
A promising outlook for new gentle breast cancer therapies
Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this years German Congress of Senology.
New cancer risk gene found
Carrying a mutated BRIP1 gene doubles the risk of breast cancer — by aged 70 these women's risk rises from 1-in-12 to 1-in-6.
New Cancer Drug Hope
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
EU challenge to worldwide BRCA2 gene patent
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Intergroup Exemestane Study (IES) results
Currently, five years of treatment with tamoxifen is considered the 'gold-standard' treatment for postmenopausal women with breast cancer. This drug blocks oestrogen, which can help fuel the growth of tumours in some cases.
New concepts for breast care
The new Emscher-Lippe Breast Care Centre, based in the Marienhospital in Gelsenkirchen, but serving six hospitals* and four private practices, was established following a directive issued by Germany's North Rhine-Westphalia regional government.
Small wireless device to improve cancer treatment
USA - Engineers are developing a tiny wireless device - the size of a rice grain - to be implanted in tumours to indicate the precise radiation dose received and to locate the exact position of tumours during treatment.
No reimbursement for digital screening
Interviewed by Daniela Zimmermann, Executive Director of EH, Jean Hooks, General Manager, Global Mammography at GE Healthcare, examined reasons behind the slow uptake of digital technology in some European countries, comparing this with its early adoption in the USA
Mobile mammography goes digital
Financed by the Ministry of Health, nine regional screening organisations arrange and implement the Dutch national breast cancer screening programme, in which, every two years, all women from 50-75 years of age are invited for a free mammogram at one of the 62 screening points, of which 56 are mobile vans.
Weighing up the way to go
Austria is the only 'old' EU Member State that has not implemented a national breast cancer screening programme.
